All companies
Visit website
BRAZEN BIO
OperatingBrazen Bio Inc.
Founded 2021
Helping biotech founders advance human health
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$418,598
Across 1 round since 2021
Latest share price
$1.00
Brazen Bio SAFE w/MFN 1 offering price
Financials
FY2019–FY2020 · from SEC filings · hover any figure for its source$0
2019
$0
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$90
Accounts receivable
$0
$0
Total assets
$0
$90
Short-term debt
$0
$90
Long-term debt
$0
$0
Total liabilities
$0
$90
Other
Headcount
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Fundraising history
Raised $418.6K / $1.1MInvestors 272
Reg CF annual-report compliance
Delinquent
Filed 0 of 5 annual reports (FY2021–FY2025)
Missing: 2021, 2022, 2023, 2024, 2025
272 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form CJul 14, 20210001670254-21-000802EDGAR
Source: ManualCIK 0001867548Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.